Given the ample evidence for the major role of lipid metabolism in tumor progression in cancer in general, but also in the context of PCa [11, 12], we studied the immunohistochemical protein expression of FABP4 and CD36, both key players in fatty-acid metabolism. The gene discussed is FABP4; the disease is cancer.